BCISE
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 18 May 2024)
What this means for you
Registered since 12 Jun 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86584499
- Registration number
- 5492498
- Mark type
- Stylized text
- Filed
- 01 Apr 2015
- Published for opposition
- 01 Mar 2016
- Registered
- 12 Jun 2018
- Attorney of record
- Cara M. Kearney
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of metabolic diseases and disorders
Owner
- AstraZeneca Pharmaceuticals LP, Wilmington, DE, US
- AstraZeneca Pharmaceuticals LP, Wilmington, DE, US
- AstraZeneca Pharmaceuticals LP, Wilmington, DE, US
Prosecution history
- 18 May 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 18 May 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 18 May 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 15 Nov 2023 — TEAS SECTION 8 & 15 RECEIVED
- 12 Jun 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 22 Jul 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 22 Jul 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 22 Jul 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 22 Jul 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Jul 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 12 Jun 2018 — REGISTERED-PRINCIPAL REGISTER
- 09 May 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 May 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Apr 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Apr 2018 — USE AMENDMENT FILED